ICCC
IMMUCELL CORP /DE/
Key Financials
Net Income
$-1040027
↑ 51.8%
Operating Income
$1.6M
↑ 200.6%
Gross Profit
$11.4M
↑ 44.1%
Revenue
$27.6M
↑ 4.3%
Shareholders' Equity
$27.1M
↓ 1.7%
Total Assets
$42.5M
↓ 5.7%
Total Liabilities
$15.5M
↓ 12.0%
Cash & Equivalents
$3.8M
↑ 1.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ICCC |
| Company Name | IMMUCELL CORP /DE/ |
| CIK | 811641 |
| SIC Code | 2835 |
| SIC Description | In Vitro & In Vivo Diagnostic Substances |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 2078782770 |